Trexquant Investment’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-95,487
Closed -$1.96M 2159
2026
Q1
$1.96M Buy
95,487
+60,889
+176% +$1.37M 0.01% 1005
2025
Q4
$820K Buy
+34,598
New +$842K 0.01% 1238
2025
Q3
Sell
-117,547
Closed -$2.7M 1840
2025
Q2
$2.7M Sell
117,547
-28,094
-19% -$650K 0.03% 779
2025
Q1
$3.27M Buy
145,641
+57,652
+66% +$1.34M 0.04% 679
2024
Q4
$1.72M Buy
+87,989
New +$1.74M 0.02% 919
2023
Q2
Sell
-11,343
Closed -$313K 1731
2023
Q1
$313K Buy
+11,343
New +$299K 0.01% 1184
2022
Q4
Sell
-15,459
Closed -$527K 1661
2022
Q3
$527K Buy
+15,459
New +$572K 0.02% 788
2022
Q2
Sell
-8,390
Closed -$224K 1795
2022
Q1
$224K Buy
+8,390
New +$198K 0.01% 1149

Other funds holding PRVA

Trexquant Investment's PRVA Position: Q2 2026 in Review

Trexquant Investment sold out of Privia Health (PRVA) in Q2 2026, closing a stake of 95,487 shares — an estimated $1.96M sold.

Trexquant Investment first reported a position in PRVA in Q1 2022 and held it in 8 quarters. The position peaked at $3.27M in Q1 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Trexquant Investment reported no remaining Privia Health position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 95,487 Privia Health shares in Q2 2026, an estimated $1.96M.
  • Trexquant Investment first reported a position in Privia Health in Q1 2022 and held it in 8 quarters.
  • Trexquant Investment's Privia Health position peaked at $3.27M in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.